Insider Transactions in Q4 2020 at Pacira Bio Sciences, Inc. (PCRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Laura Brege Director |
SELL
Open market or private sale
|
Direct |
12,000
-60.24%
|
$780,000
$65.95 P/Share
|
|
Nov 16
2020
|
Laura Brege Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+37.59%
|
$156,000
$13.98 P/Share
|
|
Nov 13
2020
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
25,000
-35.13%
|
$1,575,000
$63.09 P/Share
|
|
Nov 13
2020
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+39.06%
|
$1,050,000
$42.54 P/Share
|
|
Nov 13
2020
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.57%
|
$310,000
$62.0 P/Share
|
|
Nov 13
2020
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
3,000
-18.54%
|
$189,000
$63.81 P/Share
|
|
Nov 13
2020
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.64%
|
$30,000
$10.81 P/Share
|
|
Oct 16
2020
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-14.75%
|
$1,650,000
$55.56 P/Share
|
|
Oct 16
2020
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.85%
|
$300,000
$10.81 P/Share
|
|
Oct 15
2020
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-14.75%
|
$1,650,000
$55.0 P/Share
|
|
Oct 15
2020
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.85%
|
$300,000
$10.81 P/Share
|
|
Oct 14
2020
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
30,000
-14.75%
|
$1,650,000
$55.53 P/Share
|
|
Oct 14
2020
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.85%
|
$300,000
$10.81 P/Share
|